A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Jihui Hao) · haojihui@tjmuch.com · +86-022-23340123
Contact: Principal Investigator (Jihui Hao)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Abroad (travel likely)RecruitingPHASE1

Shanghai, China